Ikeda H, Komatsu M, Seino S, Takahashi K, Yasui S, Mariko M
First Department of Internal Medicine, Yamagata University School of Medicine.
Kaku Igaku. 1990 Jul;27(7):719-24.
123I-IMP is taken up by the pulmonary capillary endothelial cells during the first pass through the lung, and is slowly released from them. To look up the factors which influence on the prolonged 123I-IMP retention in the diseased lung, we examined the correlation between the 123I-IMP uptake during the first pass and the 123I-IMP retention. Patients with bronchial asthma had no abnormal finding in the chest X-ray photograph. However 123I-IMP release from their lungs was delayed. Some patients show a tendency that 123I-IMP uptake during the first pass was uneven, which suggested the change in amine uptake function of endothelial cells. However their correlation coefficients between the uptake during the first pass and the prolonged retention were very small. It was considered that the prolonged 123I-IMP retention in the diseased lung was not explained only by the change in uptake function of pulmonary capillary endothelial cell.
123I-碘代安非他明(123I-IMP)在首次通过肺部时被肺毛细血管内皮细胞摄取,并从这些细胞中缓慢释放。为了查找影响123I-IMP在患病肺部滞留时间延长的因素,我们研究了首次通过时123I-IMP摄取与123I-IMP滞留之间的相关性。支气管哮喘患者胸部X线照片无异常发现。然而,123I-IMP从他们肺部的释放延迟。一些患者表现出首次通过时123I-IMP摄取不均匀的趋势,这提示内皮细胞胺摄取功能发生了变化。然而,首次通过时的摄取与延长滞留之间的相关系数非常小。认为123I-IMP在患病肺部滞留时间延长不能仅用肺毛细血管内皮细胞摄取功能的变化来解释。